» Articles » PMID: 6808912

Trapping of Nonhydrolyzable Cephalosporins by Cephalosporinases in Enterobacter Cloacae and Pseudomonas Aeruginosa As a Possible Resistance Mechanism

Overview
Specialty Pharmacology
Date 1982 May 1
PMID 6808912
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Resistance to cefotaxime (CTA) and ceftriaxone (CTR) in Enterobacter cloacae and Pseudomonas aeruginosa was investigated in several strains which are susceptible or resistant to these agents. All strains produced a chromosomally mediated cephalosporinase of the Richmond type 1. beta-Lactamases in susceptible strains were inducible, whereas resistant strains produced the enzymes constitutively. CTA and CTR were very poor substrates but potent inhibitors of all enzymes. Binding to, rather than hydrolysis by, beta-lactamases was assumed to be a major reason for resistance, and combination experiments supported this assumption. Dicloxacillin, which did not inhibit the growth and which was a poor inducer but a strong inhibitor of these beta-lactamases, exerted strong synergistic activity when combined with CTA or CTR in strains which produced large amounts of beta-lactamase constitutively. Cefoxitin, on the other hand, poorly active alone, but a good inducer, strongly antagonized CTA or CTR in susceptible strains producing inducible enzymes. In marked contrast to CTA and CTR were the findings with cefsulodin. Cefsulodin was active against CTA- and CTR-resistant Pseudomonas, and its activity was hardly influenced by dicloxacillin or cefoxitin. Since cefsulodin was found to have a very low affinity for all cephalosporinases, these findings corroborate the assumption that binding of nonhydrolyzable cephalosporins, rather than hydrolysis by cephalosporinases, may play an important role in resistance to these agents and other newer cephalosporins in Enterobacteriaceae, as well as in other gram-negative bacteria.

Citing Articles

Class C β-Lactamases: Molecular Characteristics.

Philippon A, Arlet G, Labia R, Iorga B Clin Microbiol Rev. 2022; 35(3):e0015021.

PMID: 35435729 PMC: 9491196. DOI: 10.1128/cmr.00150-21.


Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.

Goessens W, van der Bij A, van Boxtel R, Pitout J, van Ulsen P, Melles D Antimicrob Agents Chemother. 2013; 57(8):3941-9.

PMID: 23733461 PMC: 3719783. DOI: 10.1128/AAC.02459-12.


Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.

Drawz S, Babic M, Bethel C, Taracila M, Distler A, Ori C Biochemistry. 2009; 49(2):329-40.

PMID: 19925018 PMC: 2810401. DOI: 10.1021/bi9015988.


AmpC beta-lactamases.

Jacoby G Clin Microbiol Rev. 2009; 22(1):161-82, Table of Contents.

PMID: 19136439 PMC: 2620637. DOI: 10.1128/CMR.00036-08.


Method for estimation of low outer membrane permeability to beta-lactam antibiotics.

Lakaye B, Dubus A, Joris B, Frere J Antimicrob Agents Chemother. 2002; 46(9):2901-7.

PMID: 12183245 PMC: 127435. DOI: 10.1128/AAC.46.9.2901-2907.2002.


References
1.
Hamilton-Miller J . The demonstration and significance of synergism between -lactam antibiotics. J Med Microbiol. 1971; 4(2):227-37. DOI: 10.1099/00222615-4-2-227. View

2.
Richmond M, Sykes R . The beta-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol. 1973; 9:31-88. DOI: 10.1016/s0065-2911(08)60376-8. View

3.
OCallaghan C, Morris A . Inhibition of beta-lactamases by beta-lactam antibiotics. Antimicrob Agents Chemother. 1972; 2(6):442-8. PMC: 444337. DOI: 10.1128/AAC.2.6.442. View

4.
Farrar Jr W, Newsome J . Mechanism of synergistic effects of beta-lactam antibiotic combinations on gram-negative bacilli. Antimicrob Agents Chemother. 1973; 4(2):109-14. PMC: 444514. DOI: 10.1128/AAC.4.2.109. View

5.
Ross G, OCALLAGHAN C . Beta-lactamase assays. Methods Enzymol. 1975; 43:69-85. DOI: 10.1016/0076-6879(75)43081-6. View